Vendor review
Shanghai Baoju reviews
Shanghai Baoju reviews from 102 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Shanghai Baoju legit? See what its vials showed.
What the lab tests show
102 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 24, 2026 | Retatrutide | 99.9 % | 18.3 mg of 20 mg (-9 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99.9 % | 49.9 mg of 50 mg (0 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 17.9 mg of 20 mg (-11 %) | Pass | View |
| Sep 24, 2026 | Tirzepatide | 99.9 % | 9.99 mg of 10 mg (0 %) | Pass | View |
| Sep 16, 2026 | Tirzepatide | 100 % | 10.4337 mg of 20 mg (-48 %) | Pass | View |
| Sep 4, 2026 | Retatrutide | 99.9 % | 28.7 mg of 30 mg (-4 %) | Pass | View |
| Sep 4, 2026 | KPV | 99 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Aug 15, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Aug 15, 2026 | Tirzepatide | 99.8 % | 19.1 mg of 20 mg (-4 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 30.6 mg of 30 mg (2 %) | Pass | View |
| Jul 17, 2026 | Retatrutide | 99.9 % | 9.76 mg of 10 mg (-2 %) | Pass | View |
| Jul 14, 2026 | Tirzepatide | 99.6 % | 13 mg of 15 mg (-13 %) | Pass | View |
| Jul 13, 2026 | Tirzepatide | 99.9 % | 9.38 mg of 10 mg (-6 %) | Pass | View |
| Jul 13, 2026 | GHK-Cu | 99.9 % | 51.4 mg of 50 mg (3 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.9 % | 50.7 mg of 40 mg (27 %) | Pass | View |
| Jun 24, 2026 | KPV | 98.7 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Jun 17, 2026 | BPC-157 | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jun 17, 2026 | TB-500 | 97.5 % | 9.02 mg of 10 mg (-10 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.9 % | 8.83 mg of 10 mg (-12 %) | Pass | View |
| Jun 15, 2026 | Tesamorelin | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jun 15, 2026 | Ipamorelin | 99.5 % | 11 mg of 10 mg (10 %) | Pass | View |
| Jun 15, 2026 | GHK-Cu | 99.8 % | 99 mg of 100 mg (-1 %) | Pass | View |
| Jun 12, 2026 | KPV | 99.2 % | 10 mg of 10 mg (0 %) | Pass | View |
| Jun 8, 2026 | Retatrutide | 99.6 % | 11.7 mg of 15 mg (-22 %) | Pass | View |
| May 27, 2026 | Tirzepatide | 99.9 % | 31.9 mg of 30 mg (6 %) | Pass | View |
| May 27, 2026 | Tirzepatide | 99.9 % | 20 mg of 20 mg (0 %) | Pass | View |
| May 27, 2026 | Retatrutide | 99.9 % | 9.14 mg of 10 mg (-9 %) | Pass | View |
| May 27, 2026 | BPC-157 | 99.3 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| May 18, 2026 | BPC-157 | 99.6 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| May 13, 2026 | Tirzepatide | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| May 13, 2026 | GHK-Cu | 99.5 % | 47.4 mg of 50 mg (-5 %) | Pass | View |
| May 13, 2026 | GHK-Cu | 99.6 % | 56.6 mg of 50 mg (13 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 27.6 mg of 30 mg (-8 %) | Pass | View |
| May 8, 2026 | Cagrilintide | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| May 6, 2026 | GHK-Cu | 99.9 % | 52.3 mg of 50 mg (5 %) | Pass | View |
| May 5, 2026 | TB-500 | 98.4 % | 5.05 mg of 5 mg (1 %) | Pass | View |
| May 5, 2026 | BPC-157 | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| May 5, 2026 | GHK-Cu | 99.9 % | 55.4 mg of 50 mg (11 %) | Pass | View |
| Apr 30, 2026 | Tirzepatide | 99.7 % | 33.1 mg of 30 mg (10 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.5 % | 9.97 mg of 10 mg (0 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 30.8 mg of 30 mg (3 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 98.4 % | 9.42 mg of 10 mg (-6 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 4.97 mg of 5 mg (-1 %) | Pass | View |
| Apr 23, 2026 | Tirzepatide | 99.9 % | 47 mg of 40 mg (18 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 98.3 % | 4.95 mg of 5 mg (-1 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Mar 25, 2026 | Retatrutide | 99.8 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Mar 21, 2026 | GHK-Cu | 99.7 % | 97.3 mg of 100 mg (-3 %) | Pass | View |
| Mar 20, 2026 | Tirzepatide | 99.7 % | 14.8 mg of 15 mg (-1 %) | Pass | View |
| Mar 20, 2026 | Retatrutide | 99.8 % | 11 mg of 10 mg (10 %) | Pass | View |
| Mar 18, 2026 | Tirzepatide | 99.9 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 17.3 mg of 20 mg (-14 %) | Pass | View |
| Mar 12, 2026 | Tirzepatide | 99.9 % | 43.2 mg of 50 mg (-14 %) | Pass | View |
| Mar 12, 2026 | Tirzepatide | 99.9 % | 34 mg of 40 mg (-15 %) | Pass | View |
| Mar 12, 2026 | Retatrutide | 99.9 % | 16.7 mg of 15 mg (11 %) | Pass | View |
| Mar 12, 2026 | Retatrutide | 99.9 % | 4.28 mg of 5 mg (-2 %) | Pass | View |
| Mar 10, 2026 | BPC-157 | 99.9 % | 5.13 mg of 5 mg (3 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 25.2 mg of 30 mg (-16 %) | Pass | View |
What Shanghai Baoju sells
No current listings on record.
About Shanghai Baoju
Finnrick has tested 101 samples from Shanghai Baoju across 9 products.